|
Net income (loss)
|
|
($341)
|
($1.0m)
|
($158.4m)
|
($288.4m)
|
($98.7m)
|
($36.6m)
|
$29.8m
|
|
Net Income From Continuing Operations
|
|
—
|
—
|
—
|
($288.4m)
|
($98.7m)
|
($36.6m)
|
$29.8m
|
|
Depreciation and amortization expense
|
|
—
|
—
|
$83.6m
|
$174.5m
|
$162.8m
|
$150.4m
|
$138.0m
|
|
Amortization of debt issuance costs
|
|
—
|
—
|
$3.2m
|
$3.5m
|
$3.1m
|
$3.1m
|
$4.2m
|
|
Amortization Cash Flow
|
|
—
|
—
|
—
|
$145.8m
|
$131.3m
|
$118.5m
|
$102.4m
|
|
Amortization Of Intangibles
|
|
—
|
—
|
—
|
$145.8m
|
$131.3m
|
$118.5m
|
$102.4m
|
|
Depreciation
|
|
—
|
—
|
—
|
$28.7m
|
$31.5m
|
$31.9m
|
$35.6m
|
|
Depreciation Amortization Depletion
|
|
—
|
—
|
—
|
$174.5m
|
$162.8m
|
$150.4m
|
$138.0m
|
|
Change in deferred income taxes
|
|
—
|
—
|
($16.6m)
|
($37.2m)
|
($30.9m)
|
($23.8m)
|
($22.3m)
|
|
Deferred Income Tax
|
|
—
|
—
|
—
|
($37.2m)
|
($30.9m)
|
($23.8m)
|
($22.3m)
|
|
Deferred Tax
|
|
—
|
—
|
—
|
($37.2m)
|
($30.9m)
|
($23.8m)
|
($22.3m)
|
|
Asset Impairment Charge
|
|
—
|
—
|
—
|
$212.7m
|
$2.3m
|
$5.2m
|
$1.6m
|
|
Loss on debt extinguishment
|
|
—
|
—
|
$0
|
$0
|
$2.6m
|
$0
|
$5.8m
|
|
Loss on disposal of property, plant and equipment and badges
|
|
—
|
—
|
($100k)
|
$3.4m
|
$600k
|
$500k
|
$600k
|
|
Stock-based compensation expense
|
|
—
|
—
|
$0
|
$31.8m
|
$21.9m
|
$15.6m
|
$15.2m
|
|
Provision for doubtful accounts
|
|
—
|
—
|
$2.1m
|
$300k
|
$1.8m
|
$3.4m
|
$2.5m
|
|
Inventory obsolescence write down
|
|
—
|
—
|
$700k
|
$900k
|
$2.3m
|
$5.2m
|
$1.6m
|
|
(Gain) loss on foreign currency transactions
|
|
—
|
—
|
$13.4m
|
$4.9m
|
($300k)
|
$2.2m
|
($17.4m)
|
|
Increase in fair values of warrant liabilities
|
|
—
|
—
|
$0
|
($37.6m)
|
$24.8m
|
$5.3m
|
$0
|
|
(Gain) loss on disposal of business
|
|
—
|
—
|
$0
|
$0
|
$6.5m
|
($1.2m)
|
$0
|
|
Other
|
|
—
|
—
|
$1.4m
|
$3.6m
|
($600k)
|
$1.8m
|
$1.0m
|
|
Accounts receivable
|
|
—
|
—
|
($4.2m)
|
($14.8m)
|
($5.0m)
|
($12.0m)
|
$14.6m
|
|
Costs in excess of billings on uncompleted contracts
|
|
—
|
—
|
($3.8m)
|
($4.5m)
|
$1.9m
|
($23.9m)
|
($7.7m)
|
|
Inventories
|
|
—
|
—
|
($4.2m)
|
($34.8m)
|
($500k)
|
$1.3m
|
$3.3m
|
|
Deferred cost of revenue
|
|
—
|
—
|
$6.6m
|
($800k)
|
$700k
|
$300k
|
($100k)
|
|
Prepaid expenses and other current assets
|
|
—
|
—
|
($10.1m)
|
($2.4m)
|
($14.0m)
|
($2.6m)
|
($9.4m)
|
|
Accounts payable
|
|
$341
|
$965k
|
$2.6m
|
$4.5m
|
($9.9m)
|
($1.5m)
|
($10.8m)
|
|
Accrued expenses and other current liabilities
|
|
—
|
—
|
($2.2m)
|
$5.5m
|
$2.6m
|
$11.3m
|
($300k)
|
|
Deferred contract revenue
|
|
—
|
—
|
($2.8m)
|
$6.9m
|
$23.9m
|
($1.1m)
|
($900k)
|
|
Other assets
|
|
—
|
—
|
$500k
|
$5.4m
|
$300k
|
$900k
|
($1.3m)
|
|
Other liabilities
|
|
—
|
—
|
$7.5m
|
($3.4m)
|
($700k)
|
$500k
|
($3.1m)
|
|
Proceeds from net investment hedge derivative contracts
|
|
—
|
—
|
$0
|
$500k
|
$3.8m
|
$3.6m
|
$2.7m
|
|
Proceeds from business disposal
|
|
—
|
—
|
$0
|
$0
|
$1.0m
|
$2.5m
|
$0
|
|
Stock repurchased to satisfy tax withholding for vesting restricted stock units
|
|
—
|
—
|
—
|
—
|
($1.0m)
|
($2.0m)
|
($6.4m)
|
|
Purchases of stock for treasury
|
|
—
|
—
|
$0
|
$0
|
($1.0m)
|
($2.0m)
|
($49.6m)
|
|
Proceeds from issuance of convertible senior notes, net of bank costs
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
$755.0m
|
|
Third-party issuance costs for convertible senior notes
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
($1.4m)
|
|
Purchase of capped calls related to convertible senior notes
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
($82.6m)
|
|
Term loan principal repayments
|
|
$0
|
($300k)
|
($14.8m)
|
($6.6m)
|
($127.3m)
|
$0
|
($244.6m)
|
|
Financing costs
|
|
—
|
—
|
$0
|
$0
|
$0
|
($1.3m)
|
($3.8m)
|
|
Proceeds from cash flow hedge derivative contracts
|
|
—
|
—
|
$0
|
$0
|
$600k
|
$1.0m
|
$700k
|
|
Beginning Cash Position
|
|
—
|
—
|
—
|
$85.3m
|
$75.0m
|
$130.5m
|
$175.6m
|
|
Cash Flow From Continuing Financing Activities
|
|
—
|
—
|
—
|
($7.0m)
|
$22.6m
|
($3.3m)
|
$775.9m
|
|
Cash Flow From Continuing Investing Activities
|
|
—
|
—
|
—
|
($39.5m)
|
($64.7m)
|
($43.7m)
|
($694.6m)
|
|
Change In Account Payable
|
|
—
|
—
|
—
|
$4.5m
|
($9.9m)
|
($1.5m)
|
($10.8m)
|
|
Change In Accrued Expense
|
|
—
|
—
|
—
|
$5.5m
|
$2.6m
|
$11.3m
|
($300k)
|
|
Change In Inventory
|
|
—
|
—
|
—
|
($34.8m)
|
($500k)
|
$1.3m
|
$3.3m
|
|
Change In Other Current Assets
|
|
—
|
—
|
—
|
$5.4m
|
$300k
|
$900k
|
($1.3m)
|
|
Change In Other Current Liabilities
|
|
—
|
—
|
—
|
($3.4m)
|
($700k)
|
$500k
|
($3.1m)
|
|
Change In Other Working Capital
|
|
—
|
—
|
—
|
$6.1m
|
$24.6m
|
($800k)
|
($1.0m)
|
|
Change In Payable
|
|
—
|
—
|
—
|
$4.5m
|
($9.9m)
|
($1.5m)
|
($10.8m)
|
|
Change In Payables And Accrued Expense
|
|
—
|
—
|
—
|
$10.0m
|
($7.3m)
|
$9.8m
|
($11.1m)
|
|
Change In Prepaid Assets
|
|
—
|
—
|
—
|
($2.4m)
|
($14.0m)
|
($2.6m)
|
($9.4m)
|
|
Change In Receivables
|
|
—
|
—
|
—
|
($19.3m)
|
($3.1m)
|
($35.9m)
|
$6.9m
|
|
Change In Working Capital
|
|
—
|
—
|
—
|
($38.4m)
|
($700k)
|
($26.8m)
|
($15.7m)
|
|
Changes In Account Receivables
|
|
—
|
—
|
—
|
($14.8m)
|
($5.0m)
|
($12.0m)
|
$14.6m
|
|
Changes In Cash
|
|
—
|
—
|
—
|
($7.1m)
|
$53.1m
|
$52.1m
|
$224.6m
|
|
End Cash Position
|
|
—
|
—
|
—
|
$75.0m
|
$130.5m
|
$175.6m
|
$415.2m
|
|
Financing Cash Flow
|
|
—
|
—
|
—
|
($7.0m)
|
$22.6m
|
($3.3m)
|
$775.9m
|
|
Free Cash Flow
|
|
—
|
—
|
—
|
$5.2m
|
$58.1m
|
$50.3m
|
$106.9m
|
|
Gain Loss On Investment Securities
|
|
—
|
—
|
—
|
($37.6m)
|
$24.8m
|
$5.3m
|
—
|
|
Gain Loss On Sale Of Business
|
|
—
|
—
|
—
|
$0
|
$6.5m
|
($1.2m)
|
$0
|
|
Gain Loss On Sale Of PPE
|
|
—
|
—
|
—
|
$3.4m
|
$600k
|
$500k
|
$600k
|
|
Investing Cash Flow
|
|
—
|
—
|
—
|
($39.5m)
|
($64.7m)
|
($43.7m)
|
($694.6m)
|
|
Issuance Of Capital Stock
|
|
—
|
—
|
—
|
$0
|
$150.0m
|
$0
|
$425.0m
|
|
Net Business Purchase And Sale
|
|
—
|
—
|
—
|
($6.6m)
|
($30.4m)
|
$1.5m
|
($661.9m)
|
|
Net Foreign Currency Exchange Gain Loss
|
|
—
|
—
|
—
|
$4.9m
|
($300k)
|
$2.2m
|
($17.4m)
|
|
Net PPE Purchase And Sale
|
|
—
|
—
|
—
|
($33.4m)
|
($37.1m)
|
($48.8m)
|
($35.4m)
|
|
Operating Gains Losses
|
|
—
|
—
|
—
|
($29.3m)
|
$34.2m
|
$6.8m
|
($11.0m)
|
|
Other Non Cash Items
|
|
—
|
—
|
—
|
$13.4m
|
$2.5m
|
$4.9m
|
$5.2m
|
|
Provisionand Write Offof Assets
|
|
—
|
—
|
—
|
$300k
|
$1.8m
|
$3.4m
|
$2.5m
|
|
Purchase Of Business
|
|
—
|
—
|
—
|
($6.6m)
|
($31.4m)
|
($1.0m)
|
($661.9m)
|
|
Purchase Of PPE
|
|
—
|
—
|
$6.0m
|
($34.2m)
|
($37.1m)
|
($48.8m)
|
($36.4m)
|
|
Repurchase Of Capital Stock
|
|
—
|
—
|
—
|
$0
|
($1.0m)
|
($2.0m)
|
($56.0m)
|
|
Sale Of Business
|
|
—
|
—
|
—
|
$0
|
$1.0m
|
$2.5m
|
$0
|
|
Sale Of PPE
|
|
—
|
—
|
—
|
$800k
|
$0
|
$0
|
$1.0m
|
|
Stock Based Compensation
|
|
—
|
—
|
—
|
$31.8m
|
$21.9m
|
$15.6m
|
$15.2m
|
|
Net cash provided by operating activities
|
|
$0
|
($945k)
|
$53.6m
|
$39.4m
|
$95.2m
|
$99.1m
|
$143.3m
|
|
Proceeds from disposal of property, plant, and equipment and badges
|
|
—
|
—
|
$0
|
$800k
|
$0
|
$0
|
$1.0m
|
|
Purchases of property, plant, and equipment and badges
|
|
—
|
—
|
($23.2m)
|
($34.2m)
|
($37.1m)
|
($48.8m)
|
($36.4m)
|
|
Acquisitions of businesses, net of cash and cash equivalents acquired
|
|
—
|
—
|
($290.1m)
|
($6.6m)
|
($31.4m)
|
($1.0m)
|
($661.9m)
|
|
Net Investment Purchase And Sale
|
|
—
|
—
|
—
|
$500k
|
$3.8m
|
$3.6m
|
$2.7m
|
|
Sale Of Investment
|
|
—
|
—
|
—
|
$500k
|
$3.8m
|
$3.6m
|
$2.7m
|
|
Other investing
|
|
—
|
—
|
$0
|
$0
|
($1.0m)
|
$0
|
$0
|
|
Net cash used in investing activities
|
|
—
|
—
|
($313.3m)
|
($39.5m)
|
($64.7m)
|
($43.7m)
|
($694.6m)
|
|
Issuance Of Debt
|
|
—
|
—
|
—
|
$0
|
$0
|
$0
|
$755.0m
|
|
Long Term Debt Issuance
|
|
—
|
—
|
—
|
$0
|
$0
|
$0
|
$755.0m
|
|
Net Issuance Payments Of Debt
|
|
—
|
—
|
—
|
($6.6m)
|
($127.3m)
|
$0
|
$510.4m
|
|
Net Long Term Debt Issuance
|
|
—
|
—
|
—
|
($6.6m)
|
($127.3m)
|
$0
|
$510.4m
|
|
Net Short Term Debt Issuance
|
|
—
|
—
|
—
|
$0
|
$0
|
—
|
—
|
|
Short Term Debt Issuance
|
|
—
|
—
|
—
|
$0
|
$0
|
—
|
—
|
|
Long Term Debt Payments
|
|
—
|
—
|
—
|
($6.6m)
|
($127.3m)
|
$0
|
($244.6m)
|
|
Repayment Of Debt
|
|
—
|
—
|
—
|
($6.6m)
|
($127.3m)
|
$0
|
($244.6m)
|
|
Issuances of common stock
|
|
$0
|
$0
|
$0
|
$0
|
$150.0m
|
$0
|
$425.0m
|
|
Common stock issuance costs
|
|
$0
|
($613k)
|
$0
|
$0
|
($300k)
|
$0
|
($15.3m)
|
|
Common Stock Issuance
|
|
—
|
—
|
—
|
$0
|
$150.0m
|
$0
|
$425.0m
|
|
Net Common Stock Issuance
|
|
—
|
—
|
—
|
$0
|
$149.0m
|
($2.0m)
|
$369.0m
|
|
Common Stock Payments
|
|
—
|
—
|
—
|
$0
|
($1.0m)
|
($2.0m)
|
($56.0m)
|
|
Other financing
|
|
—
|
—
|
$0
|
($400k)
|
$600k
|
($1.0m)
|
($1.1m)
|
|
Net Other Financing Charges
|
|
—
|
—
|
—
|
($400k)
|
$900k
|
($1.3m)
|
($103.5m)
|
|
Net cash provided by (used in) financing activities
|
|
$0
|
$751.4m
|
$239.0m
|
($7.0m)
|
$22.6m
|
($3.3m)
|
$775.9m
|
|
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
|
|
—
|
—
|
$3.1m
|
($3.2m)
|
$2.4m
|
($7.0m)
|
$15.0m
|
|
Effect Of Exchange Rate Changes
|
|
—
|
—
|
—
|
($3.2m)
|
$2.4m
|
($7.0m)
|
$15.0m
|
|
Net increase in cash, cash equivalents, and restricted cash
|
|
$0
|
$750.4m
|
($17.6m)
|
($10.3m)
|
$55.5m
|
$45.1m
|
$239.6m
|
|
Cash, cash equivalents, and restricted cash at beginning of period
|
|
$5k
|
$750.4m
|
$102.4m
|
$75.0m
|
$130.5m
|
$175.6m
|
$415.2m
|
|
Change In Cash Supplemental As Reported
|
|
—
|
—
|
—
|
($10.3m)
|
$55.5m
|
$45.1m
|
$239.6m
|